DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinomaAllison M. Kirk, Paul G. Thomas, Jeremy Chase Crawford et al.|Cell Reports Medicine|2024Cited by 15